BACKGROUND: Use of four or more prescription medications is considered a risk factor for falls in older people. It is unclear whether this polypharmacy-fall relationship differs for adults with diabetes. OBJECTIVE: We evaluated the association between number of prescription medications and incident falls in a multi-ethnic population of type-2 diabetes patients in order to establish an evidence-based medication threshold for fall risk in diabetes. DESIGN: Baseline survey (1994-1997) with 5 years of longitudinal follow-up. PARTICIPANTS: Eligible subjects (N = 46,946) had type-2 diabetes, were >or=18 years old, and enrolled in the Kaiser Permanente Northern California Diabetes Registry. MEASUREMENTS AND MAIN RESULTS: We identified clinically recognized incident falls based on diagnostic codes (ICD-9 codes: E880-E888). Relative to regimens of 0-1 medications, regimens including 4 or more prescription medications were significantly associated with an increased risk of falls [4-5 medications adjusted HR 1.22 (1.04, 1.43), 6-7 medications 1.33 (1.12, 1.58), >7 medications 1.59 (1.34, 1.89)]. None of the individual glucose-lowering medications was found to be significantly associated with a higher risk of falls in predictive models. CONCLUSIONS: The prescription of four or more medications was associated with an increased risk of falls among adult diabetes patients, while no specific glucose-lowering agent was linked to increased risk. Baseline risk of falls and number of baseline medications are additional factors to consider when deciding whether to intensify diabetes treatments.
BACKGROUND: Use of four or more prescription medications is considered a risk factor for falls in older people. It is unclear whether this polypharmacy-fall relationship differs for adults with diabetes. OBJECTIVE: We evaluated the association between number of prescription medications and incident falls in a multi-ethnic population of type-2 diabetespatients in order to establish an evidence-based medication threshold for fall risk in diabetes. DESIGN: Baseline survey (1994-1997) with 5 years of longitudinal follow-up. PARTICIPANTS: Eligible subjects (N = 46,946) had type-2 diabetes, were >or=18 years old, and enrolled in the Kaiser Permanente Northern California Diabetes Registry. MEASUREMENTS AND MAIN RESULTS: We identified clinically recognized incident falls based on diagnostic codes (ICD-9 codes: E880-E888). Relative to regimens of 0-1 medications, regimens including 4 or more prescription medications were significantly associated with an increased risk of falls [4-5 medications adjusted HR 1.22 (1.04, 1.43), 6-7 medications 1.33 (1.12, 1.58), >7 medications 1.59 (1.34, 1.89)]. None of the individual glucose-lowering medications was found to be significantly associated with a higher risk of falls in predictive models. CONCLUSIONS: The prescription of four or more medications was associated with an increased risk of falls among adult diabetespatients, while no specific glucose-lowering agent was linked to increased risk. Baseline risk of falls and number of baseline medications are additional factors to consider when deciding whether to intensify diabetes treatments.
Authors: D W Bates; E B Miller; D J Cullen; L Burdick; L Williams; N Laird; L A Petersen; S D Small; B J Sweitzer; M Vander Vliet; L L Leape Journal: Arch Intern Med Date: 1999-11-22
Authors: Jinan B Saaddine; Betsy Cadwell; Edward W Gregg; Michael M Engelgau; Frank Vinicor; Giuseppina Imperatore; K M Venkat Narayan Journal: Ann Intern Med Date: 2006-04-04 Impact factor: 25.391
Authors: Hertzel C Gerstein; Michael E Miller; Robert P Byington; David C Goff; J Thomas Bigger; John B Buse; William C Cushman; Saul Genuth; Faramarz Ismail-Beigi; Richard H Grimm; Jeffrey L Probstfield; Denise G Simons-Morton; William T Friedewald Journal: N Engl J Med Date: 2008-06-06 Impact factor: 91.245
Authors: Elbert S Huang; Anirban Basu; Michael Finch; Jennifer Frytak; Willard Manning Journal: Curr Med Res Opin Date: 2007-05-14 Impact factor: 2.580
Authors: Ann V Schwartz; Eric Vittinghoff; Deborah E Sellmeyer; Kenneth R Feingold; Nathalie de Rekeneire; Elsa S Strotmeyer; Ronald I Shorr; Aaron I Vinik; Michelle C Odden; Seok Won Park; Kimberly A Faulkner; Tamara B Harris Journal: Diabetes Care Date: 2007-12-04 Impact factor: 19.112
Authors: Tanya M Wildes; Ronald J Maggiore; William P Tew; David Smith; Can-Lan Sun; Harvey Cohen; Supriya G Mohile; Ajeet Gajra; Heidi D Klepin; Cynthia Owusu; Cary P Gross; Hyman Muss; Andrew Chapman; Stuart M Lichtman; Vani Katheria; Arti Hurria Journal: Support Care Cancer Date: 2018-04-28 Impact factor: 3.603
Authors: Samuel F Freedman; Carrie Johnston; John J Faragon; Eugenia L Siegler; Tessa Del Carmen Journal: Eur Geriatr Med Date: 2018-12-06 Impact factor: 1.710
Authors: Urmimala Sarkar; Courtney Lyles; Michael Steinman; Elbert S Huang; Howard H Moffet; Rachel A Whitmer; E Margaret Warton; Andrew J Karter Journal: J Am Geriatr Soc Date: 2016-09-19 Impact factor: 5.562
Authors: Carlos A Vaz Fragoso; Peter H Van Ness; Katy L B Araujo; Lynne P Iannone; Richard A Marottoli Journal: J Am Geriatr Soc Date: 2013-09-03 Impact factor: 5.562